Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
41 hedge funds and large institutions have $11.6M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 11 closing their positions.
1,250% more call options, than puts
Call options by funds: $27K | Put options by funds: $2K
16% less funds holding
Funds holding: 49 → 41 (-8)
19% less capital invested
Capital invested by funds: $14.4M → $11.6M (-$2.8M)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$431K |
| 2 |
Renaissance Technologies
New York
|
+$177K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.52K |
| 4 |
Citigroup
New York
|
+$6.52K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$5.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$958K |
| 2 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$438K |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$201K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$92K |
| 5 |
Morgan Stanley
New York
|
-$78.3K |
FRTX Hedge Fund Activity: Q4 2015 in Review
41 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q4 2015, worth a combined $11.6M — down 19% from $14.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of FRTX and 3 opened new positions — a net loss of 8 holders — while 11 trimmed existing stakes and 5 added.
The largest buyer was Fidelity Investments, adding an estimated $431K. The largest seller was RA Capital Management, exiting entirely with an estimated $958K sold.
- 41 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q4 2015, down from 49 in Q3 2015.
- Funds reported $11.6M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q4 2015, down 19% quarter-over-quarter.
- 3 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q4 2015 and 11 closed out, a net change of -8 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q4 2015 was Fidelity Investments, an estimated $431K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q4 2015 was RA Capital Management, an estimated $958K sold.
Based on aggregated 13F filings for Q4 2015.